U.S. Pharmaceuticals & Biotech Most Popular Stocks

Real Brands

Market Cap: US$2.7k

Produces and sells hemp cannabinoids oil and related products.

AmeriCann

Market Cap: US$2.4k

Designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States.

OncoVista Innovative Therapies

Market Cap: US$2.4k

A biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers.

Longport

Market Cap: US$2.3k

Develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States.

Suvanza Pharma

Market Cap: US$2.2k

Operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases.

Applied Biosciences

Market Cap: US$2.1k

Focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas.

Juva Life

Market Cap: US$1.6k

Acquires, owns, and operates in cannabis business in medical and recreational cannabis sectors in California, the United States.

Innoveren Scientific

Market Cap: US$1.6k

A medical bioscience company that develops technology in regenerative medicine for limb salvage.

MedMen Enterprises

Market Cap: US$1.6k

Operates as a cannabis retailer in the United States.

Kali

Market Cap: US$1.5k

Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses.

Parallel Industries

Market Cap: US$1.3k

Does not have significant operations.

Evolutionary Genomics

Market Cap: US$1.3k

Engages in the research and identification of positively selected genes in humans, animals, and commercial crops.

South American Gold

Market Cap: US$1.3k

South American Gold Corp. is focused on becoming the premiere provider of value added products and services for the cultivation and processing of cannabis for the South American medical and recreational markets with an initial focus on the Uruguayan market.

DNAPrint Genomics

Market Cap: US$1.3k

Engages in the development and marketing of genetic testing products and services.

Viropro

Market Cap: US$1.3k

Through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases.

GlobeStar Therapeutics

Market Cap: US$1.2k

A clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States.

MetaStat

Market Cap: US$1.2k

A precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients.

PhaseRx

Market Cap: US$1.2k

A biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy.

BioSyntech

Market Cap: US$1.2k

Develops biotherapeutic thermogels for tissue repair and therapeutic delivery.

Pilot Therapeutics Holdings

Market Cap: US$1.2k

Pilot Therapeutics Holdings Inc. develops and manufactures pharmaceutical products for treatment of dysfunctional lipid metabolism.

Arrayit

Market Cap: US$1.1k

A life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide.

Manzo Pharmaceuticals

Market Cap: US$1.1k

A specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies.

BellRock Brands

Market Cap: US$1.1k

Develops, markets, and sells cannabis products in the United States, Canada, and internationally.

Rising BioSciences

Market Cap: US$1.1k

Develops and manufactures topical and oral pharmaceutical products, including medical marijuana products.

OpGen

Market Cap: US$1.0k

A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

Omnimmune Holdings

Market Cap: US$980.0

Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States.

eFFECTOR Therapeutics

Market Cap: US$940.0

A biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.

BioELife

Market Cap: US$940.0

Operates in cannabinoid market.

Advantis

Market Cap: US$878.0

Develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors.

Praxsyn

Market Cap: US$847.0

A health care company, provides medical practitioners with medications and services for their patients.

Sunniva

Market Cap: US$795.0

A vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States.

Profile Solutions

Market Cap: US$776.0

Through its subsidiary, Elite Products International, Inc., manufactures and distributes cannabinoid hemp extracts in the form of edibles, creams, oils, and salves.

Clever Leaves Holdings

Market Cap: US$701.0

Operates in the botanical cannabinoid and nutraceutical industries.

Item 9 Labs

Market Cap: US$701.0

Operates as a vertically integrated cannabis operator and dispensary franchisor in the United States.

Pathfinder Cell Therapy

Market Cap: US$667.0

A development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage.

Amarantus BioScience Holdings

Market Cap: US$630.0

A biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine.